Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 12 | $1,805,541 |
Sells | 6 | $49,486,066 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 May 2024 06:15 | LSEA | Landsea Homes Corp | TIAN MING | Director , 10% | 14 May 2024 | Sale | 4,100,000 | 6 | 24,600,000 | I |
15 May 2024 06:15 | LSEA | Landsea Homes Corp | LANDSEA HOLDINGS CORP | 10% | 14 May 2024 | Sale | 4,100,000 | 6 | 24,600,000 | D |
15 May 2024 07:31 | BHVN | Biohaven Ltd. | BAILEY GREGORY | Director | 13 May 2024 | Purchase | 15,000 | 34.1918 | 512,877 | D |
15 May 2024 09:11 | LSAK | LESAKA TECHNOLOGIES INC | MAZANDERANI ALI | Executive Chairman | 14 May 2024 | Purchase | 52,418 | 5.14 | 269,429 | D |
15 May 2024 08:36 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | CONWAY VIKKI L | See Remarks | 13 May 2024 | Sale | 15,219 | 16.7427 | 254,807 | D |
15 May 2024 07:19 | BCRX | BIOCRYST PHARMACEUTICALS INC | DOYLE ANTHONY | Chief Financial Officer | 14 May 2024 | Purchase | 36,300 | 5.57 | 202,191 | D |
15 May 2024 07:17 | BCRX | BIOCRYST PHARMACEUTICALS INC | THACKRAY HELEN M. | Chief R&D Officer | 14 May 2024 | Purchase | 30,000 | 5.86 | 175,800 | D |
15 May 2024 07:08 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 13 May 2024 | Purchase | 30,000 | 5.55 | 166,500 | D |
15 May 2024 07:04 | BCRX | BIOCRYST PHARMACEUTICALS INC | GAYER CHARLES K | Chief Commercial Officer | 13 May 2024 | Purchase | 30,000 | 5.47 | 164,100 | D |
15 May 2024 07:14 | BCRX | BIOCRYST PHARMACEUTICALS INC | GALSON STEVEN K | Director | 13 May 2024 | Purchase | 21,940 | 5.49 | 120,451 | D |
15 May 2024 08:36 | HAIN | HAIN CELESTIAL GROUP INC | BOYCE LEE A. | EVP & Chief Financial Officer | 13 May 2024 | Purchase | 13,500 | 7.665 | 103,478 | D |
15 May 2024 09:44 | KRNY | Kearny Financial Corp | PIVIROTTO CHARLES J | Director | 13 May 2024 | Purchase | 5,160 | 5.7633 | 29,739 | D |
15 May 2024 07:11 | BCRX | BIOCRYST PHARMACEUTICALS INC | BARNES ALANE P | Chief Legal Officer | 13 May 2024 | Purchase | 5,000 | 5.53 | 27,650 | D |
15 May 2024 06:13 | ETST | Earth Science Tech Inc | SANCHEZ YOVAN ARTURO | Director | 14 May 2024 | Purchase | 150,000 | 0.135 | 20,250 | D |
15 May 2024 09:37 | CURI | CuriosityStream Inc | NIKZAD MICHAEL | Director | 14 May 2024 | Sale | 15,676 | 1.1301 | 17,715 | D |
15 May 2024 09:16 | NVCT | Nuvectis Pharma Inc | BENTSUR RON | Chairman & CEO, 10% | 14 May 2024 | Purchase | 1,940 | 6.74 | 13,076 | D |
15 May 2024 08:52 | BPRN | Princeton Bancorp Inc | ADKINS STEPHANIE | Chief Lending Officer | 14 May 2024 | Sale | 265 | 30.0482 | 7,963 | D |
15 May 2024 09:37 | CURI | CuriosityStream Inc | NIKZAD MICHAEL | Director | 13 May 2024 | Sale | 4,923 | 1.1337 | 5,581 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)